Small cell carcinoma of prostate (SCPCa) was initially described by Wenk et al. in 1977. SCPCa is a very rare cancer that accounts for only 0.5-2% of all prostate carcinomas. Although, this pathology is usually accompanied with prostate adenocarcinomas, there are a few hypotheses about the origin of SCPCa. Poorly differentiated acinar adenocarcinoma must be distinguished from SCPCa in histopathological examination. These patients may present with different paraneoplastic syndromes. Early diagnosis is very important because of the aggressive tumor behavior. Here, we report a patient who presented with Cushing syndrome and thereafter diagnosed with SCPCa
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Ectopic adrenocorticotropin (ACTH) secretion accounts for less than 10% of all causes of endogenous ...
Aim and background. Small cell carcinoma of the prostate (SCCP) is a relatively rare entity, an aggr...
A 75-year-old man was hospitalized because of severe hypokalaemia due to ACTH dependent Cushing’s sy...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
An 82-year-old man, who 7 years previously had been treated for adenocarcinoma of the prostate, was ...
Small cell carcinoma(SCC) of prostate is a very rare and highly aggressive neoplasm which constitut...
ObjectiveExtrapulmonary small cell carcinoma (EPSCC) is rare and frequent metastases at presentation...
AbstractSmall cell carcinoma (SCC) of the prostate is a high-grade malignant neoplasm with neuroendo...
Primary small cell carcinoma of the prostate (SCPCa) is a rare pathologic entity with unique clinica...
Small cell carcinoma (SCC) of the prostate is rare in the spectrum of prostate tumors. Clinically, p...
Pure small cell carcinoma of the prostate is ex-tremely rare. When it does occur, it is usually in c...
Small cell carcinoma of the prostate is associated with poor prognosis and different treatment from ...
The small cell carcinoma is a neuroendocrine tumour characterised by an aggressive clinical course a...
Small cell carcinoma of the prostate is rare, accounting for approximately 1% of all prostatic cance...
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Ectopic adrenocorticotropin (ACTH) secretion accounts for less than 10% of all causes of endogenous ...
Aim and background. Small cell carcinoma of the prostate (SCCP) is a relatively rare entity, an aggr...
A 75-year-old man was hospitalized because of severe hypokalaemia due to ACTH dependent Cushing’s sy...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
An 82-year-old man, who 7 years previously had been treated for adenocarcinoma of the prostate, was ...
Small cell carcinoma(SCC) of prostate is a very rare and highly aggressive neoplasm which constitut...
ObjectiveExtrapulmonary small cell carcinoma (EPSCC) is rare and frequent metastases at presentation...
AbstractSmall cell carcinoma (SCC) of the prostate is a high-grade malignant neoplasm with neuroendo...
Primary small cell carcinoma of the prostate (SCPCa) is a rare pathologic entity with unique clinica...
Small cell carcinoma (SCC) of the prostate is rare in the spectrum of prostate tumors. Clinically, p...
Pure small cell carcinoma of the prostate is ex-tremely rare. When it does occur, it is usually in c...
Small cell carcinoma of the prostate is associated with poor prognosis and different treatment from ...
The small cell carcinoma is a neuroendocrine tumour characterised by an aggressive clinical course a...
Small cell carcinoma of the prostate is rare, accounting for approximately 1% of all prostatic cance...
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Ectopic adrenocorticotropin (ACTH) secretion accounts for less than 10% of all causes of endogenous ...
Aim and background. Small cell carcinoma of the prostate (SCCP) is a relatively rare entity, an aggr...